Back to Search
Start Over
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure
- Source :
- Neurobiology of aging. 86
- Publication Year :
- 2019
-
Abstract
- Despite the great effort of the scientific community in the field, the pathogenesis of frontotemporal dementia (FTD) remains elusive. Recently, a role for autoimmunity and altered glutamatergic neurotransmission in triggering disease onset has been put forward. We reported the presence of autoantibodies recognizing the GluA3 subunit of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in about 25% of FTD cases. In this study, we evaluated the mechanisms involved in anti-GluA3 autoimmunity, through molecular/neurochemical analyses conducted on patients' brain specimens with frontotemporal lobar degeneration–tau neuropathology. We then corroborated these results in vivo in FTD patients with transcranial magnetic stimulation and glutamate, D-serine, and L-serine dosages in the cerebrospinal fluid and serum. We observed that GluA3 autoantibodies affect glutamatergic neurotransmission, decreasing glutamate release and altering GluA3-containing α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor levels. These alterations were accompanied by changes of scaffolding proteins involved in receptor synaptic retention/internalization. The above results were confirmed by transcranial magnetic stimulation, suggesting a significant impairment of indirect measures of glutamatergic neurotransmission in FTD patients compared with controls, with further add-on harmful effect in those FTD patients with anti-GluA3 antibodies. Finally, FTD patients showed a significant increase of glutamate, D-serine, and L-serine levels in the cerebrospinal fluid.
- Subjects :
- 0301 basic medicine
AMPA receptors
Autoimmunity
Cerebrospinal fluid
Dementia
Glutamate
Synapses
Adult
Male
Aging
Female
Frontotemporal Dementia
Glutamates
Humans
Middle Aged
Receptors, AMPA
Autoantibodies
Synaptic Transmission
AMPA receptor
Neuropathology
Neurotransmission
03 medical and health sciences
Glutamatergic
0302 clinical medicine
Neurochemical
Receptors
AMPA
mental disorders
medicine
business.industry
General Neuroscience
Glutamate receptor
medicine.disease
Synapse
030104 developmental biology
Neurology (clinical)
Geriatrics and Gerontology
business
Neuroscience
030217 neurology & neurosurgery
Developmental Biology
Frontotemporal dementia
Subjects
Details
- ISSN :
- 15581497
- Volume :
- 86
- Database :
- OpenAIRE
- Journal :
- Neurobiology of aging
- Accession number :
- edsair.doi.dedup.....59ad7f31a792fec30f5ab6893ac59c93